Galenica Sante (Switzerland) Today

GALE Stock  CHF 75.20  0.40  0.53%   

Performance

4 of 100

 
Low
 
High
Insignificant

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Galenica Sante is selling for under 75.20 as of the 29th of March 2024; that is 0.53 percent up since the beginning of the trading day. The stock's lowest day price was 74.3. Galenica Sante has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Galenica Sante AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 29th of March 2024. Click here to learn more.
Galenica AG operates as a healthcare provider in Switzerland and internationally. The company was incorporated in 2017 and is headquartered in Bern, Switzerland. Galenica Sant operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. The company has 49.64 M outstanding shares. More on Galenica Sante AG

Moving against Galenica Stock

  0.49EVE Evolva Holding SAPairCorr
  0.47HBMN HBM Healthcare InvesPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Galenica Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Galenica Sante's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Galenica Sante or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Galenica Sante AG (GALE) is traded on SIX Swiss Exchange in Switzerland and employs 5,517 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Galenica Sante's market, we take the total number of its shares issued and multiply it by Galenica Sante's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Galenica Sante AG operates under Healthcare sector and is part of Biotechnology industry. The entity has 49.64 M outstanding shares. Galenica Sante AG has accumulated about 164.98 M in cash with 333.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.13.
Check Galenica Sante Probability Of Bankruptcy
Ownership Allocation
Galenica Sante secures a total of 49.64 Million outstanding shares. 30% of Galenica Sante AG outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Galenica Ownership Details

Galenica Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Galenica Sante jumping above the current price in 90 days from now is about 47.45%. The Galenica Sante AG probability density function shows the probability of Galenica Sante stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Galenica Sante AG has a beta of -0.1007. This usually indicates as returns on benchmark increase, returns on holding Galenica Sante are expected to decrease at a much lower rate. During the bear market, however, Galenica Sante AG is likely to outperform the market. Additionally, galenica Sante AG has an alpha of 0.0594, implying that it can generate a 0.0594 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 75.2HorizonTargetOdds Above 75.2
51.92%90 days
 75.20 
47.45%
Based on a normal probability distribution, the odds of Galenica Sante to move above the current price in 90 days from now is about 47.45 (This Galenica Sante AG probability density function shows the probability of Galenica Stock to fall within a particular range of prices over 90 days) .

Galenica Sante AG Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Galenica Sante market risk premium is the additional return an investor will receive from holding Galenica Sante long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Galenica Sante. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Galenica Sante's alpha and beta are two of the key measurements used to evaluate Galenica Sante's performance over the market, the standard measures of volatility play an important role as well.

Galenica Stock Against Markets

Picking the right benchmark for Galenica Sante stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Galenica Sante stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Galenica Sante is critical whether you are bullish or bearish towards Galenica Sante AG at a given time. Please also check how Galenica Sante's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Galenica Sante without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Galenica Sante Corporate Management

Elected by the shareholders, the Galenica Sante's board of directors comprises two types of representatives: Galenica Sante inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galenica. The board's role is to monitor Galenica Sante's management team and ensure that shareholders' interests are well served. Galenica Sante's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galenica Sante's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Galenica Stock?

Before investing in Galenica Sante, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Galenica Sante. To buy Galenica Sante stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Galenica Sante. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Galenica Sante stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Galenica Sante AG stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Galenica Sante AG stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Galenica Sante AG, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Galenica Sante AG?

The danger of trading Galenica Sante AG is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Galenica Sante is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Galenica Sante. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Galenica Sante AG is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Galenica Stock analysis

When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Please note, there is a significant difference between Galenica Sante's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galenica Sante is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galenica Sante's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.